Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled trial of human fibrin sealant for hemostasis in liver surgery
CTR20254119Phase 3Active
- Sponsor
- Sichuan Yuanda Shuyang Pharmaceutical
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of tachosil in Not applicable, sponsored by Sichuan Yuanda Shuyang Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
tachosil
03
Conditions
Not applicable
Beyond the preview
Go deeper on CTR20254119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254119.